School of Medicine
Showing 21-40 of 180 Results
-
Marilyn Tan
Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Current Research and Scholarly InterestsType 2 diabetes, obesity, insulin resistance
-
Miranda Tan, DO
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Tan is a board-certified sleep medicine physician with the Sleep Medicine Center at Stanford Health Care. She is also a clinical associate professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.
Dr. Tan specializes in diagnosing and treating common and rare sleep disorders. Her multidisciplinary approach to care is focused on improving patients’ quality of life and long-term health. Dr. Tan is fellowship-trained and board-certified in sleep medicine, pulmonary medicine, and critical care medicine.
Some of Dr. Tan’s research has focused on improving the understanding of fatigue and sleep disorders in cancer patients and survivors. Her work has also highlighted the positive potential of artificial intelligence and machine learning to enhance diagnostic methods for sleep disorders.
Dr. Tan has published her work in numerous prestigious peer-reviewed journals, including the American Journal of Respiratory and Critical Care Medicine, Chest, and the Journal of Clinical Sleep Medicine. She has also been an invited guest speaker and moderator at national meetings, including those for the American College of Chest Physicians and the American Academy of Sleep Medicine.
Dr. Tan is a fellow of the American College of Chest Physicians and a member of the American Academy of Sleep Medicine and the American Thoracic Society. -
Pedro Tanaka
Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
BioPedro Tanaka is a Clinical Professor in the Department of Anesthesia at Stanford University Medical School. He is Brazilian and completed medical school, anesthesiology training, and his PhD in clinical investigation in Brazil. He graduated from the Master of Academic Medicine program at the University of Southern California in 2014 and completed a doctoral program in education at the University of Illinois at Chicago in 2021. At Stanford, he has been involved with resident education as an Associate Program Director and served as the inaugural Vice-Chair for Diversity, Equity, and Inclusion in the Department of Anesthesiology. He currently serves as an Associate Designated Institutional Official for Graduate Medical Education and Associate Dean for Academic Affairs. He is also thrilled to be an Assistant Director with COACHME. Leveraging a rich foundation in Medicine, Education, Leadership, and Executive Coaching, He offers a unique blend of methodologies designed to empower faculty members on their journey of self-discovery within the academic environment. His approach is tailored to assist clinician-educators in mastering the challenges of their roles, enhancing their educational impact, and advancing their careers in academic medicine.
-
Molly Tanenbaum
Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Clinical Assistant Professor (By courtesy), Pediatrics - Endocrinology and DiabetesBioDr. Tanenbaum is a clinical researcher committed to improving health and quality of life outcomes for people with diabetes. Dr. Tanenbaum’s research focuses on two main areas: 1) understanding and optimizing the role of technology (e.g. mobile technology/mHealth, diabetes devices, closed-loop systems), and the feedback technology provides, to improve diabetes management; and 2) understanding the emotional experience of living with diabetes. Her recent work has focused on developing a telehealth-based behavioral intervention for adults with type 1 diabetes to support adoption and sustained use of continuous glucose monitoring technology. She has expertise in using qualitative and mixed methods to take a human centered approach to understanding the context of living with and managing a chronic condition. Dr. Tanenbaum also has an interest in compassion-based approaches to addressing diabetes distress. As a licensed clinical psychologist, Dr. Tanenbaum provides consultation and behavioral medicine interventions with people living with diabetes.
-
Hua Tang
Professor of Genetics and, by courtesy, of Statistics
Current Research and Scholarly InterestsDevelop statistical and computational methods for population genomics analyses; modeling human evolutionary history; genetic association studies in admixed populations.
-
Jean Y. Tang MD PhD
Professor of Dermatology
On Partial Leave from 10/07/2024 To 10/06/2025Current Research and Scholarly InterestsMy research focuses on 2 main areas:
1. Skin cancer:
- New therapeutics to treat and prevent non-melanoma skin cancer, especially by targeting the Hedgehog signaling pathway for BCC tumors
- Genomic analysis of drug-resistant cancers
- Identifying risk factors for skin cancer in the Women's Health Initiative
2. Epidermolysis Bullosa: gene therapy and protein therapy to replace defective/absent Collagen 7 in children and adults with Recessive Dystrophic EB -
Paul C Tang
Other Teaching Staff-Hourly, Medicine - Primary Care and Population Health
BioDr. Tang is Adjunct Professor in the Clinical Excellence Research Center at Stanford University and a practicing internist at the Palo Alto Medical Foundation. Most recently, he was Vice President, Chief Health Transformation Officer at IBM Watson Health. He has served in executive administration roles in health systems for over 25 years. Prior to joining Watson Health, Dr. Tang was Vice President, Chief Innovation and Technology Officer at the Palo Alto Medical Foundation (PAMF), directing the David Druker Center for Health Systems Innovation, a disruptive innovation center focused on grand challenges in health. Dr. Tang led one of the earliest implementations of an Electronic Health Record (EHR) system in the country in 1996, and in 2000, he co-developed MyChart, the first commercial patient portal, with Epic.
Dr. Tang is an elected member of the National Academy of Medicine, and has served on numerous NAM study committees, including a patient-safety committee he chaired that published two reports: Patient Safety: A New Standard for Care, and Key Capabilities of an Electronic Health Record System. He is a member of the Health and Medicine Division committee of the National Academies of Science, Engineering, and Medicine. Dr. Tang was co-chair of the federal Health Information Technology Policy committee from 2009-2017. He has served as board chair for several health informatics professional associations, including the American Medical Informatics Association (AMIA). He has served on the boards of AMIA, National Quality Forum, AcademyHealth, Computer-based Patient Record Institute, Joint Health Information Technology Alliance, NAM Board on Health Care Services, and National eHealth Collaborative. Dr. Tang is a recipient of the Nicholas E. Davies Award for Excellence in Computer-based Patient Record System Implementation, and the AMIA Don E. Detmer Award for Health Policy Contributions in Informatics. He currently holds one patent and has 16 patents pending. He has published numerous papers in medical informatics, appearing in New England Journal of Medicine, JAMA, Health Affairs, Annals of Internal Medicine, and Journal of the American Medical Informatics Association. Dr. Tang is a Fellow of the American College of Physicians, the American College of Medical Informatics, the College of Healthcare Information Management Executives, and the Healthcare Information and Management Systems Society.
He received his B.S. and M.S. in Electrical Engineering from Stanford University and his M.D. from the University of California, San Francisco. He completed his residency in internal medicine at Stanford University and is a board-certified practicing internist at the Palo Alto Medical Foundation. -
Sindy Tang
Associate Professor of Mechanical Engineering, Senior Fellow at the Woods Institute for the Environment and Professor, by courtesy, of Radiology and of Bioengineering
Current Research and Scholarly InterestsThe long-term goal of Dr. Tang's research program is to harness mass transport in microfluidic systems to accelerate precision medicine and material design for a future with better health and environmental sustainability.
Current research areas include: (I) Physics of droplets in microfluidic systems, (II) Interfacial mass transport and self-assembly, and (III) Applications in food allergy, single-cell wound repair, and the bottom-up construction of synthetic cell and tissues in close collaboration with clinicians and biochemists at the Stanford School of Medicine, UCSF, and University of Michigan.
For details see https://web.stanford.edu/group/tanglab/ -
Sami Gamal-Eldin Tantawi
Professor of Particle Physics and Astrophysics, Emeritus
BioFor over a decade I have advocated for dedicated research efforts on the basic physics of room temperature high gradient structures and new initiatives for the associated RF systems. This required demanding multidisciplinary collaboration to harness limited resources. The basic elements of the research needed to be inclusive to address not only the fundamentals of accelerator structures but also the fundamentals of associated technologies such as RF manipulation and novel microwave power sources. These basic research efforts were not bundled with specific developments for an application or a general program. The emerging technologies promise a broad, transformational impact.
With this underlying philosophy in mind, in 2006 the US High Gradient Research Collaboration for which I am the spokesman was formed. SLAC is the host of this collaboration, which comprises MIT, ANL, University of Maryland and University of Colorado, NRL and a host of SBIR companies. This led to the revitalization of this research area worldwide. The international collaborative effort grew to include KEK in Japan, INFN, Frascati in Italy, the Cockcroft Institute in the UK, and the CLIC team at CERN.
This effort led to a new understanding of the geometrical effects affecting high gradient operations. The collaborative work led to new advances in understanding the gradient limits of photonic band gap structures. Now we have a new optimization methodology for accelerator structure geometries and ongoing research on alternate and novel materials. These efforts doubled the usable gradient in normal conducting high gradient linacs to more than 100 MV/m, thus revitalizing the spread of the technology to other applications including compact Inverse Compton Scattering gamma-ray sources for national security applications, and compact proton linacs for cancer therapy.
